Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Asbury Ronald Andrews


  • Chief Executive Officer at Oncocyte Corp (OCX), 2019-07-03
  • Director at Oxford Immunotec Global Plc (OXFD), 2019-06-19
  • President, Medical Sciences at Life Technologies Corp (LIFE), 2014-02-04
  • Vice-Chairman And Ceo at Clarient Inc (CLRT), 2010-12-23
  • Director at Cardiac Science Corp (CSCX), 2010-12-07
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
OCX $0.00 17,482 Director 17,482 2018-07-26 Filing
LIFE $46.49 3,330 Officer 3,330 2012-04-27 Filing
CLRT $2.41 12,000 Officer, Director 72,500 2010-03-12 Filing